In the future, self-driving cars will make highways and roads safer for everyone. But if Google’s latest report on self-driving car accidents is any indicator, we have a long way to go before our robot overlords will save us.
What do you do if you’re a medical technology startup while waiting for the FDA to approve your flagship iPhone-based product?
If you’re AliveCor, you launch a veterinary version of it.
The product in question is AliveCor’s iPhone ECG heart monitor, which the company showed off nearly two years ago, at the CES in 2011. The device allows a medical professional to assess a patient’s heart rhythm, providing more data than a stethoscope or manual check of their pulse. Although the device has broad potential, it has yet to be approved by the FDA.
Seeking to challenge the iPad’s ongoing success in the healthcare field, Panasonic has announced an updated version of Toughbook tablet for doctors offices and hospitals. The update is the latest for Toughbook product line that Panasonic introduced in 2008.
The 10-inch screen size is about the only thing in the new Toughbook CF-H2 Health tablet offers that is similar to the iPad. The Toughbook is a Windows 7 tablet powered by an Intel Core i5 processor that relies on a 320GB hard drive rather than flash memory for storage (though a 128 GB SSD is available as a custom build option). It weighs in at a whopping 1.58 kg (3.48 pounds) – more than double the weight of the new iPad.
The Toughbook, which will ship next month, will have an entry-level price of €1,898 (approximately $2,330). That’s more than four times the cost of an entry-level new iPad and just shy of six times the cost of the entry-level iPad 2.
Apple CEO Tim Cook has been invited to participate in a roundtable discussion at the National Comprehensive Cancer Network’s (NCCN) annual conference on clinical practice guidelines and quality cancer care. The topic of the discussion is Cancer and Corporate America: Business As Usual. At the moment it isn’t clear if Cook will attend (NCCN lists both speakers that have confirmed their attendance as well as those that have not).
The invitation raises some questions about why the organization chose to invite Cook. One obvious answer centers around the role that Cook played in managing Apple while Steve Jobs was fighting the pancreatic cancer that eventually led to his death last year. While that is certainly plausible, there could be other reasons behind NCCN’s invitation.